CDSCO regulatory advisory for COVID-19

On 19th March 2020, the Central Drugs Standard Control Organization, announced that in order to encourage the research and development of a drug or vaccine for prevention or treatment of COVID-19, or in-vitro diagnostic kits for the diagnosis of COVID-19, will be processed on high priority. CDSCO shall also provide the required guidance for the regulatory pathway of such applications. Please refer to the circulars issued by the CDSCO, on the following links:

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *